People are dying after self-medicating with unproven COVID-19 drug promoted by Trump

Anti-malaria drugs
(Image credit: Gerard Julien/AFP/Getty Images)

President Trump has touted the decades-old anti-malaria drug chloroquine and its less-toxic cousin hydroxychloroquine as promising treatments for the COVID-19 coronavirus in press briefings and on Twitter, despite warnings from top federal health officials that the drugs aren't approved to fight COVID-19 and could have harmful side effects. The publicity has led to a run on the drugs, leaving people who use it to treat lupus and arthritis unable to fill their prescriptions. There have also been deaths.

Nigeria reported two fatal overdoses of chloroquine after Trump's remarks and its Center for Disease Control pleaded with Nigerians on Friday to not self-medicate with a drug that "will cause harm and can lead to death." Closer to home, a man in Arizona died and his wife is in the hospital after they ingested a version of chloroquine phosphate meant to clean fish tanks, the woman and Banner Health said Monday. The wife told NBC News that she and her husband got the idea to self-medicate after watching Trump's news conference.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.